Find link

language:

Find link is a tool written by Edward Betts.

searching for Dasatinib 17 found (543 total)

alternate case: dasatinib

Bafetinib (733 words) [view diff] exact match in snippet view article find links to article

T315I) and some dasatinib resistant mutations. Bafetinib also has more affinity for Bcr-Abl than nilotinib (but less than dasatinib) but only targets

Synthetic lethality (2,804 words) [view diff] exact match in snippet view article find links to article

of the DNA repair kinase ATR, or by exposure to the kinase inhibitor dasatinib. There are two pathways for homologous recombinational repair of double-strand

MD Anderson Cancer Center (5,298 words) [view diff] exact match in snippet view article find links to article

2006: FDA Approval of Dasatinib and Nilotinib for Resistant Leukemia MD Anderson researchers demonstrate the efficacy of dasatinib and nilotinib, leading

ABL2 (1,464 words) [view diff] exact match in snippet view article find links to article

Conformation in the Abl Tyrosine Kinase Domain 2gqg: X-ray Crystal Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain 2hiw: Crystal Structure

Melphalan flufenamide (2,123 words) [view diff] exact match in snippet view article find links to article

cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma". Molecular Oncology. 10 (5): 719–734. doi:10

Crystal Mackall (2,787 words) [view diff] exact match in snippet view article find links to article

exhaustion can be reversed by transient T cell rest and demonstrated that dasatinib, a commonly prescribed oral drug, could be used to rest human T cells

ABL (gene) (3,502 words) [view diff] exact match in snippet view article

Conformation in the Abl Tyrosine Kinase Domain 2gqg: X-ray Crystal Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain 2hiw: Crystal Structure

Oncogenomics (7,684 words) [view diff] exact match in snippet view article find links to article

methyltransferase activity of EZH2, or with addition of the kinase inhibitor dasatinib. Another approach is to individually knock out each gene in a genome and

Α-Ketoglutaric acid (5,479 words) [view diff] exact match in snippet view article find links to article

Holland WL, Donato AJ, Lesniewski LA (February 2023). "Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic

Cancer biomarker (5,014 words) [view diff] exact match in snippet view article find links to article

Martinelli G, Simonsson B, Guilhot F, Larson RA, et al. (October 2007). "Dasatinib induces rapid hematologic and cytogenetic responses in adult patients

The Hallmarks of Cancer (2,657 words) [view diff] exact match in snippet view article find links to article

Smith, S., Toban, N., Bazile, M., & Aloyz, R. (2013). Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated

Regulatory T cell (9,481 words) [view diff] exact match in snippet view article find links to article

by blocking tyrosine kinases. For example, tyrosine-kinase inhibitor dasatinib is used for treatment of chronic myeloid leukemia and is associated with

Inventive step under the European Patent Convention (3,395 words) [view diff] exact match in snippet view article find links to article

decisions T 355/97 and T 87/08) T 578/06, point 13 of the Reasons T 0488/16 (Dasatinib/BRISTOL-MYERS SQUIB) of 1.2.2017, reasons 4.9. Board of Appeal decision

Preclinical imaging (6,058 words) [view diff] exact match in snippet view article find links to article

(December 2017). "18[F]-Positron Emitting, Fluorescent Derivative of Dasatinib". Molecular Cancer Therapeutics. 16 (12): 2902–2912. doi:10.1158/1535-7163

2019 in science (24,667 words) [view diff] exact match in snippet view article find links to article

senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease". EBioMedicine

Giulio Superti-Furga (4,526 words) [view diff] exact match in snippet view article find links to article

"The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib". Proceedings of the National Academy of Sciences. 104 (33): 13283–13288

Engineered CAR T cell delivery (3,553 words) [view diff] exact match in snippet view article find links to article

Hermann; Hudecek, Michael (Jul 2019). "The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells". Science Translational